Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lancet (London, England)"
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22antibodies%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22antibodies%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29&lookfor=%22antibodies%22&type=Subject
PubPharm (61)
1
SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster
enthalten in:
Lancet (London, England)
| 2023
von
Wang, Q.
|
Bowen, A.
|
Ho, J.
| +6
Wird geladen...
2
Natural SARS-CoV-2 infection-induced immune protection against re-infection
enthalten in:
Lancet (London, England)
| 2023
von
Matuchansky, C.
CommentOn: Lancet. 2023 Mar 11;401(10379):833-842. - PMID 36930674
Wird geladen...
3
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing
enthalten in:
Lancet (London, England)
| 2023
von
Wijaya, R.
|
Johnson, M.
|
Campbell, N.
| +14
Wird geladen...
4
Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
enthalten in:
Lancet (London, England)
| 2023
von
Tibble, H.
|
Mueller, T.
|
Proud, E.
| +6
Wird geladen...
5
Perilous two-tier COVID-19 global vaccine roll-out
enthalten in:
Lancet (London, England)
| 2022
von
Durrheim, D.
CommentOn: Lancet. 2022 Apr 16;399(10334):1452-1453. - PMID 35218695
Wird geladen...
6
How to interpret the total number of SARS-CoV-2 infections
enthalten in:
Lancet (London, England)
| 2022
von
Shioda, K.
|
Lopman, B.
CommentOn: Lancet. 2022 Jun 25;399(10344):2351-2380. - PMID 35405084
Wird geladen...
7
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
enthalten in:
Lancet (London, England)
| 2022
von
Antonelli, M.
|
Pujol, J.
|
Spector, T.
| +2
CommentOn: Lancet Public Health. 2021 Jan;6(1):e21-e29. - PMID 33278917
Wird geladen...
8
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years : a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
enthalten in:
Lancet (London, England)
| 2022
von
Li, G.
|
Cappuccini, F.
|
Marchevsky, N.
| +70
CommentIn: Lancet. 2022 Jun 11;399(10342):2171-2173. - PMID 35691308
Wird geladen...
9
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trial
enthalten in:
Lancet (London, England)
| 2022
von
Luke, J.
|
Rutkowski, P.
|
Queirolo, P.
| +26
CommentIn: Nat Rev Clin Oncol. 2022 Jun;19(6):359. - PMID 35440772
Wird geladen...
10
Spreading of SARS-CoV-2 from hamsters to humans
enthalten in:
Lancet (London, England)
| 2022
von
Haagmans, B.
|
Koopmans, M.
CommentOn: Lancet. 2022 Mar 12;399(10329):1070-1078. - PMID 35279259
Wird geladen...
1
2
3
4
5
6
7
Nächster »
[7]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Lancet (London, England)
Medienart
61
Aufsätze
61
E-Artikel
61
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
44
Antibodies, Viral
38
Journal Article
27
COVID-19 Vaccines
26
Antibodies, Neutralizing
23
Letter
21
Research Support, Non-U.S. Gov't
17
Comment
15
Randomized Controlled Trial
8
Immunoglobulin G
8
Multicenter Study
7
Antibodies, Monoclonal, Humanized
7
Clinical Trial, Phase II
7
Clinical Trial, Phase III
6
B5S3K2V0G8
6
BNT162 Vaccine
6
ChAdOx1 nCoV-19
6
N38TVC63NU
5
I031V2H011
5
Spike Glycoprotein, Coronavirus
5
Viral Vaccines
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2023
17
2022
24
2021
16
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
61
Englisch
Haven't found what you're looking for?
Wird geladen...